Bitcoin

Crypto markets are currently driven by macro factors, adoption trends, and regulatory news. Scientific breakthroughs in neuroscience belong to a completely separate asset class (biotech equities) and do not intersect with digital assets. The market is in a slightly bullish phase with BTC dominance high, indicating risk-on sentiment within crypto itself, but this news is off-radar for traders.

A study published in Nature reports that aberrant excitatory neuronal ERBB4 promotes Alzheimer's disease pathology, and suggests neuroinflammation alone may be dispensable for early synapse loss.